Table 3.
Grade 3/4 drug-related toxicities observed in all cycles
| Grade ¾ toxicity | Level 1 (n = 3) | Level 2 (n = 6) | Level 3 (n = 18) | Level 4 (n = 3) | All (n = 30) |
|---|---|---|---|---|---|
| Anaemia | – | 3 (50 %) | 3 (16.7 %) | – | 6 (20.0 %) |
| Neutropenia | 1 (33.3 %) | 2 (33.3 %) | 7 (38.9 %) | 2 (66.7 %) | 12 (40.0 %) |
| Thrombocytopenia | – | – | 1 (5.6 %) | – | 1 (3.3 %) |
| Febrile neutropenia | – | 1 (16.7 %) | – | 1 (33.3 %) | 2 (6.7 %) |
| Diarrhoea | – | – | 1 (5.6 %) | – | 1 (3.3 %) |
| Condition aggravated | – | 1 (16.7 %) | – | – | 1 (3.3 %) |
| Fatigue | – | 2 (33.3 %) | 1 (5.6 %) | – | 3 (10.0 %) |
| Hyperbilirubinaemia | – | – | 1 (5.6 %) | – | 1 (3.3 %) |
| Hypokalaemia | – | – | 1 (5.6 %) | – | 1 (3.3 %) |
| Tumour pain | – | – | – | 1 (33.3 %) | 1 (33.3 %) |
| Pulmonary haemorrhage | – | – | 1 (5.6 %) | – | 1 (3.3 %) |
| Dermatitis acneiform | – | – | 1 (5.6 %) | – | 1 (3.3 %) |